Article

Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells

2020-08-12

Abstract excerpt

<h4>ABSTRACT</h4> SARS-CoV-2, which causes COVID-19 disease, is one of greatest global pandemics in history. No effective treatment is currently available for severe COVID-19 disease. One strategy for implementing cell-based immunity involves the use of chimeric antigen receptor (CAR) technology. Unlike CAR T cells, which need to be developed using primary T cells derived from COVID-19 patients with lymphopenia,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c422b433-b302-59e1-9435-c182022c3b77
DOI: 10.1101/2020.08.11.247320

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Targeting SARS-CoV-2 by CAR-NK CellsDOI 10.1101/2020.08.11.247320Read

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In VitroSemantic proximity Read

CAR-NK Cells Effectively Target the D614 and G614 SARS-CoV-2-infected CellsSemantic proximity Read

Identification of Cross-Reactive CD8 <sup>+</sup> T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant VariantsSemantic proximity Read

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipientsSemantic proximity Read

CAR-NK cell therapy: a potential antiviral platformSemantic proximity Read

CAR-NK cells with dual targeting of PD-L1 and MICA/B in human lung cancer H1299 cell tumor modelSemantic proximity Read

A new mRNA antigen vaccine induces potent B and T cell responses and <i>in vivo</i> protection against SARS-CoV-2Semantic proximity Read

Recent Progress in NKG2D CAR-NK Cells for Cancer ImmunotherapySemantic proximity Read

ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for <i>in vivo</i> efficacy against SARS-CoV-2Semantic proximity Read

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineSemantic proximity Read

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentSemantic proximity Read

Rapid GMP-compliant expansion of SARS-CoV-2-specific T cells from convalescent donors for use as an allogeneic cell therapy for COVID-19Semantic proximity Read